Titlebook: Disease-modifying Therapy in Vasculitides; Cees G. M. Kallenberg,Jan W. Cohen Tervaert Book 2001 Birkhäuser Verlag 2001 Internal medicine.

hexagon

书目名称Disease-modifying Therapy in Vasculitides影响因子(影响力)




书目名称Disease-modifying Therapy in Vasculitides影响因子(影响力)学科排名




书目名称Disease-modifying Therapy in Vasculitides网络公开度




书目名称Disease-modifying Therapy in Vasculitides网络公开度学科排名




书目名称Disease-modifying Therapy in Vasculitides被引频次




书目名称Disease-modifying Therapy in Vasculitides被引频次学科排名




书目名称Disease-modifying Therapy in Vasculitides年度引用




书目名称Disease-modifying Therapy in Vasculitides年度引用学科排名




书目名称Disease-modifying Therapy in Vasculitides读者反馈




书目名称Disease-modifying Therapy in Vasculitides读者反馈学科排名

可转变

1422-7746 dicine, connective tissue disease and clinical immunology, they present new concepts in classificiation, diagnosis and pathophysiology of the vasculitides. Evidence from experimental and clinical trials is reviewed, as well as the outlook for further research.978-3-0348-9485-2978-3-0348-8235-4Series ISSN 1422-7746 Series E-ISSN 2296-4525

uveitis

Philip Michalk,Bertram Meimbresse rheumatoid arthritis (RA) and Crohn’s disease has revolutionized the treatment of these diseases [.-.]. The extrapolation and rigorous testing of cytokine modulation strategies in the vasculitides have enormous potential to improve therapies for this group of disorders.

SEED

色情

NOCT

Intravenous immunoglobulin as immuno-modifying treatment,s of autoimmunity. There has been widespread clinical use of IgIV as a second line treatment for many autoimmune diseases with relatively few randomised studies demonstrating its clinical effectiveness.

NOCT

conflate

天空

似少年

,Interferon-α for the treatment of virus-related systemic vasculitides,itides with IFNα. Two types of IFNα are commonly prescribed, IFNα 2a and IFNα 2b. They differ by one amino acid but no difference in efficacy has been shown. The other types of IFN, that is, IFNβ and IFNγ, are not prescribed for virus-associated vasculitides.